Document is current
Any future updates will be listed below
-
Authors
Tagai, Kenji
Tatebe, Harutsugu
Matsuura, Sayo
Hong, Zhang
Kokubo, Naomi
Matsuoka, Kiwamu
Endo, Hironobu
Oyama, Asaka
Hirata, Kosei
Shinotoh, Hitoshi
Kataoka, Yuko
Matsumoto, Hideki
Oya, Masaki
Kurose, Shin
Takahata, Keisuke
Ichihashi, Masanori
Kubota, Manabu
Seki, Chie
Shimada, Hitoshi
Takado, Yuhei
Kawamura, Kazunori
Zhang, Ming-Rong
Soeda, Yoshiyuki
Takashima, Akihiko
Higuchi, Makoto
Tokuda, Takahiko
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18dm0207018, JP19dm0207072, JP18dk0207026, JP19dk0207049, 21wm0425015, 21dm0307003, 22dk020705)
MEXT KAKENHI (JP16H05324, JP18K07543)
Core Research for Evolutional Science and Technology (JPMJCR1652)
Moonshot Research and Development Program (JPMJMS2024)
- License Information
-
More Information
Article History
Received: 25 April 2024
Accepted: 20 August 2024
First Online: 3 September 2024
Declarations
:
: This study was approved by the National Institutes for Quantum Science and Technology Certified Review Board. Written informed consent was obtained from all participants and spouses or close family members when participants were cognitively impaired. This study was registered with the UMIN Clinical Trial Registry (UMIN-CRT; Number 000041383).
: Not applicable.
: Hitoshi Shimada, Ming-Rong Zhang, and Makoto Higuchi hold patents on compounds related to the present report (JP 5422782/EP 12 884 742.3/CA2894994/HK1208672).
